NAPLEX Practice Exam 2025 – All-in-One Guide to Mastering the North American Pharmacist Licensure Examination!

Question: 1 / 1820

What type of inhibitor is Ibalizumab-uiyk (Trogarzo)?

Post-attachment inhibitor

Ibalizumab-uiyk (Trogarzo) is a monoclonal antibody used in the treatment of HIV/AIDS. It is specifically classified as a post-attachment inhibitor, meaning it prevents the virus from binding to and entering human cells. This mechanism of action makes it different from fusion inhibitors (which prevent the virus from fusing with the cell membrane), INSTI-based drugs (which inhibit the integration of the HIV genome into human DNA), and NNRTI-based drugs (which inhibit viral reverse transcriptase). Therefore, these options are incorrect because they do not accurately describe the mode of action of Ibalizumab-uiyk.

Get further explanation with Examzify DeepDiveBeta

Fusion inhibitor

INSTI based

NNRTI-based

Next Question

Report this question

Subscribe

Get the latest from Examzify

You can unsubscribe at any time. Read our privacy policy